Longrong Wang

802 total citations
26 papers, 560 citations indexed

About

Longrong Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Longrong Wang has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Longrong Wang's work include RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Longrong Wang is often cited by papers focused on RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Longrong Wang collaborates with scholars based in China, Israel and Netherlands. Longrong Wang's co-authors include Jiamin Zhou, Yiming Zhao, Anrong Mao, Miao Wang, Xigan He, Weiping Zhu, Ti Zhang, Qi Pan, Yun Feng and Miao Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Longrong Wang

26 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longrong Wang China 14 327 248 114 112 104 26 560
Zhishi Yang China 9 174 0.5× 212 0.9× 98 0.9× 98 0.9× 122 1.2× 10 432
Mitsuhiro Hishida Japan 12 309 0.9× 152 0.6× 91 0.8× 82 0.7× 54 0.5× 23 484
Yifeng Tian China 16 479 1.5× 413 1.7× 203 1.8× 102 0.9× 104 1.0× 37 775
Shengguang Yuan China 15 469 1.4× 259 1.0× 231 2.0× 101 0.9× 61 0.6× 21 728
Ketuan Huang China 14 317 1.0× 270 1.1× 134 1.2× 136 1.2× 30 0.3× 32 517
Tao Song China 12 238 0.7× 140 0.6× 111 1.0× 54 0.5× 63 0.6× 28 506
Guohe Song China 10 216 0.7× 142 0.6× 131 1.1× 91 0.8× 51 0.5× 19 471
Manqing Cao China 11 421 1.3× 309 1.2× 125 1.1× 57 0.5× 31 0.3× 17 601
Chuanyong Zhang China 13 382 1.2× 231 0.9× 156 1.4× 49 0.4× 57 0.5× 25 630
Yaliang Lan China 9 360 1.1× 296 1.2× 77 0.7× 55 0.5× 51 0.5× 12 526

Countries citing papers authored by Longrong Wang

Since Specialization
Citations

This map shows the geographic impact of Longrong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longrong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longrong Wang more than expected).

Fields of papers citing papers by Longrong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longrong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longrong Wang. The network helps show where Longrong Wang may publish in the future.

Co-authorship network of co-authors of Longrong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Longrong Wang. A scholar is included among the top collaborators of Longrong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longrong Wang. Longrong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhiwen, Yixiu Wang, Yibin Wu, et al.. (2025). SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation. Cancer Letters. 625. 217770–217770. 1 indexed citations
2.
Zhou, Jiamin, Yibin Wu, Miao Wang, et al.. (2023). GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway. Oncogene. 42(45). 3319–3330. 84 indexed citations
3.
Wang, Longrong, Ning Zhang, Yixiu Wang, et al.. (2023). Safety and efficacy of GEMOX plus donafenib and tislelizumab as first‐line therapy for advanced epithelial malignant biliary tract cancer. Cancer Medicine. 12(11). 12263–12271. 4 indexed citations
4.
Fan, Shasha, Zhenhai Lin, Yong‐Fa Zhang, et al.. (2023). ZNF655 promotes the progression of hepatocellular carcinoma through PSMB8. Cell Biology International. 47(9). 1535–1546. 4 indexed citations
5.
Zhou, Jiamin, Long-Hai Feng, Xinxiang Li, et al.. (2022). The Value of Laparoscopic Simultaneous Colorectal and Hepatic Resection for Synchronous Colorectal Cancer Liver Metastasis: A Propensity Score Matching Study. Frontiers in Oncology. 12. 916455–916455. 3 indexed citations
6.
He, Xigan, Jiamin Zhou, Anrong Mao, et al.. (2022). LncRNA‐EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src‐YAP signaling axis. The FASEB Journal. 36(12). e22663–e22663. 9 indexed citations
7.
Wang, Yixiu, Yongfa Zhang, Longrong Wang, et al.. (2022). Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC. Hepatology International. 16(6). 1435–1447. 38 indexed citations
8.
Zhang, Yong‐Fa, Yixiu Wang, Zhenhai Lin, et al.. (2021). Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma. Bioengineered. 12(1). 1202–1211. 8 indexed citations
9.
Zhou, Jiamin, et al.. (2021). Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy. Frontiers in Surgery. 8. 764887–764887. 8 indexed citations
10.
Wu, Yibin, Longrong Wang, Xiaoshuang Wang, et al.. (2021). RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy. Cancer Cell International. 21(1). 464–464. 5 indexed citations
11.
Wang, Longrong, Yiming Zhao, Qi Pan, et al.. (2020). Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. Journal of Translational Medicine. 18(1). 273–273. 25 indexed citations
12.
Wang, Longrong, Kai Yan, Xigan He, et al.. (2020). LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer. 12(1). 217–223. 36 indexed citations
13.
Wang, Longrong, Miao Wang, Xigan He, et al.. (2020). Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma. The American Journal of Surgery. 222(2). 383–389. 11 indexed citations
14.
Zhou, Jiamin, Xigan He, Miao Wang, et al.. (2020). Enhanced recovery after surgery program in the patients undergoing hepatectomy for benign liver lesions. Hepatobiliary & pancreatic diseases international. 19(2). 122–128. 10 indexed citations
15.
Wang, Longrong, Li Xie, Weiping Zhu, et al.. (2019). Predictive Value of Intraoperative Indocyanine Green Clearance Measurement on Postoperative Liver Function After Anatomic Major Liver Resection. Journal of Gastrointestinal Surgery. 24(6). 1342–1351. 13 indexed citations
16.
Wang, Miao, Jiamin Zhou, Yiming Zhao, et al.. (2019). Surgical treatment of ovarian cancer liver metastasis. HepatoBiliary Surgery and Nutrition. 8(2). 129–137. 19 indexed citations
17.
Zhu, Weiping, Yiming Zhao, Xigan He, et al.. (2018). Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma. Cell Death and Disease. 9(2). 69–69. 16 indexed citations
18.
19.
Zhu, Weiping, Yiming Zhao, Jiamin Zhou, et al.. (2016). Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition. Journal of Hematology & Oncology. 9(1). 127–127. 43 indexed citations
20.
Chai, Zong‐Tao, Jian Kong, Xiao‐Dong Zhu, et al.. (2013). MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma. PLoS ONE. 8(10). e77957–e77957. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhishi Yang Breakdown of academic impact, for papers by Mitsuhiro Hishida Breakdown of academic impact, for papers by Yifeng Tian Breakdown of academic impact, for papers by Shengguang Yuan Breakdown of academic impact, for papers by Ketuan Huang Breakdown of academic impact, for papers by Tao Song Breakdown of academic impact, for papers by Guohe Song Breakdown of academic impact, for papers by Manqing Cao Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Yaliang Lan
Rankless by CCL
2026